The Mount Sinai Tisch Cancer Center (TCC) has been named a “Comprehensive Cancer Center” by the National Cancer Institute (NCI), the highest designation awarded to cancer centers in the United States. This recognition places Mount Sinai among the top one percent of cancer centers nationwide and affirms the breadth and depth of its cancer research, clinical excellence, and commitment to health equity. The designation also brings more than $3 million annually to support Mount Sinai’s research and innovation.

University of Iowa Health Care researchers have produced the most comprehensive genetic and metabolic analysis to date of the oral microbiome associated with multiple sclerosis (MS), a progressive autoimmune disease that damages nerves in the brain and spinal cord. They found that people with MS have a distinct (dysbiotic) oral microbiome compared to healthy individuals. The findings could eventually help doctors develop simple saliva-based tests to detect or monitor MS and may open the door to new classes of MS treatments that replace or restore healthy bacteria.

Corewell Health physicians are researching cancer treatment advancements with a new, nearly $2.2 million grant from the National Institutes of Health. The four-year grant will help doctors potentially bring a type of proton beam technology, called dynamic SPArc (Spot-Scanning Proton Arc), into everyday patient care.

New study led by researchers at Cincinnati Children’s proposes a way to combine previously separate data gathering approaches and concepts about blood cell formation into a more unified whole